These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1671812)

  • 1. Somatostatin and analogues in the treatment of cancer. A review.
    Evers BM; Parekh D; Townsend CM; Thompson JC
    Ann Surg; 1991 Mar; 213(3):190-8. PubMed ID: 1671812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Somatostatin analogs in oncology].
    Thomas F; Parmar H; Prevost G; Kuhn JM; Bejot JL; Moreau JP; Bogden A
    Bull Cancer; 1991; 78(8):693-707. PubMed ID: 1681967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor ligands and their use in the treatment of endocrine disorders.
    Janson ET; Oberg K
    Curr Pharm Des; 1999 Sep; 5(9):693-705. PubMed ID: 10495360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin analogues in the treatment of breast and prostate cancer.
    Manni A; Boucher AE; Demers LM; Harvey HA; Lipton A; Simmonds MA; Bartholomew M
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1083-7. PubMed ID: 1981012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of somatostatin analogues in the antiproliferative treatment of carcinomas.
    Kath R; Höffken K
    Recent Results Cancer Res; 2000; 153():23-43. PubMed ID: 10626287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin and growth hormone regulation in cancer.
    Manni A
    Biotherapy; 1992; 4(1):31-6. PubMed ID: 1347453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
    Öberg K; Lamberts SW
    Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies of somatostatin and somatostatin-analogues: therapeutic advances and perspectives.
    Moreau JP; DeFeudis FV
    Life Sci; 1987 Feb; 40(5):419-37. PubMed ID: 2880272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review.
    Arnold R; Simon B; Wied M
    Digestion; 2000; 62 Suppl 1():84-91. PubMed ID: 10940693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Long-Acting Somatostatin and GnRH Analogues and Their Applications in Tumor Therapy.
    Yu F; Zhang T; Fu F; Wang A; Liu X
    Curr Drug Deliv; 2022; 19(1):5-16. PubMed ID: 34951573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Somatostatin analogues in treatment of gastrointestinal and pancreatic neuroendocrine tumors].
    Simonenko VB; Dulin PA; Makanin MA
    Klin Med (Mosk); 2006; 84(4):4-8. PubMed ID: 16755846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Somatostatin analogues for the treatment of gastro-entero-pancreatic neuroendocrine tumours].
    Uomo G; Germano D; Rabitti PG
    Minerva Endocrinol; 2001 Dec; 26(4):225-9. PubMed ID: 11782707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers.
    Schally AV; Comaru-Schally AM; Redding TW
    Proc Soc Exp Biol Med; 1984 Mar; 175(3):259-81. PubMed ID: 6141569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future aspects of somatostatin-receptor-mediated therapy.
    Oberg K
    Neuroendocrinology; 2004; 80 Suppl 1():57-61. PubMed ID: 15477719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):248-52. PubMed ID: 6141560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
    Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
    Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of somatostatin analogues in the treatment of cancer.
    Lamberts SW; Koper JW; Reubi JC
    Eur J Clin Invest; 1987 Aug; 17(4):281-7. PubMed ID: 2889601
    [No Abstract]   [Full Text] [Related]  

  • 18. Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review.
    Chan DL; Ferone D; Albertelli M; Pavlakis N; Segelov E; Singh S
    Endocrine; 2017 Sep; 57(3):366-375. PubMed ID: 28726183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.
    Modlin IM; Pavel M; Kidd M; Gustafsson BI
    Aliment Pharmacol Ther; 2010 Jan; 31(2):169-88. PubMed ID: 19845567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.
    Raderer M; Kurtaran A; Scheithauer W; Fiebiger W; Weinlaender G; Oberhuber G
    Oncology; 2001; 60(2):141-5. PubMed ID: 11244329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.